Supplementary Figure Legends from MALAT1 is Associated with Poor Response to Oxaliplatin-Based Chemotherapy in Colorectal Cancer Patients and Promotes Chemoresistance Through EZH2

Peilong Li,Xin Zhang,Haiyan Wang,Lili Wang,Tong Liu,Lutao Du,Yongmei Yang,Chuanxin Wang

DOI: https://doi.org/10.1158/1535-7163.22509054

2023-01-01

Abstract:Figure legends for supplementary figures

What problem does this paper attempt to address?

Supplementary Figure Legends from Intracrine VEGF Signaling Mediates the Activity of Prosurvival Pathways in Human Colorectal Cancer Cells

Rajat Bhattacharya,Xiang-Cang Ye,Rui Wang,Xia Ling,Madonna McManus,Fan,Delphine Boulbes,Lee M. Ellis

DOI: https://doi.org/10.1158/0008-5472.22407995.v1

2023-01-01

Abstract:Legends for Supplementary Figures S1-S12.
Supplementary Methods and Supplementary Results from MALAT1 is Associated with Poor Response to Oxaliplatin-Based Chemotherapy in Colorectal Cancer Patients and Promotes Chemoresistance Through EZH2

Peilong Li,Xin Zhang,Haiyan Wang,Lili Wang,Tong Liu,Du Li,Yue Yang,Chuanxin Wang

DOI: https://doi.org/10.1158/1535-7163.22509042.v1

2023-01-01

Abstract:Supplementary methods and Supplementary results
Supplementary Table 2 from MALAT1 is Associated with Poor Response to Oxaliplatin-Based Chemotherapy in Colorectal Cancer Patients and Promotes Chemoresistance Through EZH2

Peilong Li,Xin Zhang,Haiyan Wang,Lili Wang,Tong Liu,Du Li,Yue Yang,Chuanxin Wang

DOI: https://doi.org/10.1158/1535-7163.22509048.v1

2023-01-01

Abstract:Supplementary Table 2 Association of MALAT1 expression with clinical parameters in CRC patients
Supplementary Table 3 from MALAT1 is Associated with Poor Response to Oxaliplatin-Based Chemotherapy in Colorectal Cancer Patients and Promotes Chemoresistance Through EZH2

Peilong Li,Xin Zhang,Haiyan Wang,Lili Wang,Tong Liu,Lutao Du,Yongmei Yang,Chuanxin Wang

DOI: https://doi.org/10.1158/1535-7163.22509045

2023-01-01

Abstract:Supplementary Table 3 Association of EZH2 and clinical factors of CRC patients
Supplementary Figure 6 from MALAT1 is Associated with Poor Response to Oxaliplatin-Based Chemotherapy in Colorectal Cancer Patients and Promotes Chemoresistance Through EZH2

Peilong Li,Xin Zhang,Haiyan Wang,Lili Wang,Tong Liu,Lutao Du,Yongmei Yang,Chuanxin Wang

DOI: https://doi.org/10.1158/1535-7163.22509057.v1

2023-01-01

Abstract:Supplementary Figure 6. ROC analysis was performed to establish the potential cut-off values of MALAT1 (A) and miR-218 (B) in 46 primary CRC tissues for distinguishing responding and non-responding patients who had received standard FOLFOX treatment.
Supplementary Figure 4 from MALAT1 Is Associated with Poor Response to Oxaliplatin-Based Chemotherapy in Colorectal Cancer Patients and Promotes Chemoresistance through EZH2

Peilong Li,Xin Zhang,Haiyan Wang,Lili Wang,Tong Liu,Lutao Du,Yongmei Yang,Chuanxin Wang

DOI: https://doi.org/10.1158/1535-7163.22509063.v1

2023-01-01

Abstract:Supplementary Figure 4. SW480 and SW620 cells were transfected with si-EZH2 for 48 hours, and then the EZH2 mRNA level (A) and protein level (B) were detected by using RT-qPCR and Western blot method, respectively. **, P<0.01;***,P<0.001.
Supplementary Figure Legend from Synergistic Activities of MET/RON Inhibitor BMS-777607 and Mtor Inhibitor AZD8055 to Polyploid Cells Derived from Pancreatic Cancer and Cancer Stem Cells

Junying Zeng,Sharad Sharma,Yong‐Qing Zhou,Hang‐Ping Yao,Xing Hu,Ruiwen Zhang,Ming-Hai Wang

DOI: https://doi.org/10.1158/1535-7163.22503690

2023-01-01

Abstract:PDF - 71K, Legends for Supplementary Figures 1 through 5.
Supplementary Figure Legends from Retinoic Acid–Related Orphan Receptor C Regulates Proliferation, Glycolysis, and Chemoresistance Via the PD-L1/ITGB6/STAT3 Signaling Axis in Bladder Cancer

Dalong Cao,Zihao Qi,Yangyang Pang,Haoran Li,Huyang Xie,Junlong Wu,Yongqiang Huang,Yao Zhu,Yijun Shen,Yiping Zhu,Bo Dai,Xin Hu,Dingwei Ye,Ziliang Wang

DOI: https://doi.org/10.1158/0008-5472.22418970

2023-01-01

Abstract:Supplementary Figure Legends
Supplementary Figure Legends from EpCAM Inhibition Sensitizes Chemoresistant Leukemia to Immune Surveillance

Xin Zheng,Xiaolei Fan,Binqing Fu,Ming–Hua Zheng,Aimei Zhang,Kai Zhong,Jun Yan,Rui Sun,Zhigang Tian,Wei H

DOI: https://doi.org/10.1158/0008-5472.22414839.v1

2023-01-01

Abstract:Supplementary Figure 1-6 legends
Supplementary Figure Legends from Nuclear Export of Ubiquitinated Proteins Determines the Sensitivity of Colorectal Cancer to Proteasome Inhibitor

Tingyu Wu,Wei Chen,Yongwang Zhong,Xiaodan Hou,Shengyun Fang,Chen-Ying Liu,Guanghui Wang,Tong Yu,Yu-Yang Huang,Xuesong Ouyang,Henry Q.X. Li,Long Cui,Yili Yang

DOI: https://doi.org/10.1158/1535-7163.22507968.v1

2023-01-01

Abstract:Bortezomib and KPT330 co-treatment inhibit patients-derived xenografts in nude mice.
Supplementary Figure Legends from ME1 Regulates NADPH Homeostasis to Promote Gastric Cancer Growth and Metastasis

Yun-Xin Lu,Huai-Qiang Ju,Ze-Xian Liu,Dong-Liang Chen,Yun Wang,Qi Zhao,Qi-Nian Wu,Zhao-lei Zeng,Hai-Bo Qiu,Pei-Shan Hu,Zhi-Qiang Wang,Dong-Sheng Zhang,Feng Wang,Rui-Hua Xu

DOI: https://doi.org/10.1158/0008-5472.22421103.v1

2023-01-01

Abstract:Figure legends for Figure S1-7.
Supplementary Figure Legends from Combination of TMB and CNA Stratifies Prognostic and Predictive Responses to Immunotherapy Across Metastatic Cancer

Li Liu,Xue Bai,Jian Wang,Xiaonan Tang,Dehua Wu,Shasha Du,Xiu-Ju Du,Yao-Wei Zhang,Hai‐Liang Zhu,Yuan Fang,Zhimou Guo,Qiandong Zeng,Xuejun Guo,Zhu Li,Zhong‐Yi Dong

DOI: https://doi.org/10.1158/1078-0432.22471917.v1

2023-01-01

Abstract:Supplementary figure legends
Figure Legends for Supplementary Figures from Analysis of Mtor Gene Aberrations in Melanoma Patients and Evaluation of Their Sensitivity to PI3K–AKT–mTOR Pathway Inhibitors

Yan Kong,Lu Si,Yiqian Li,Xiaowen Wu,Xiaowei Xu,Jie Dai,Huan Tang,Meng Ma,Zhihong Chi,Xinan Sheng,Chuanliang Cui,Jun Guo

DOI: https://doi.org/10.1158/1078-0432.22461800.v1

2023-01-01

Abstract:Figure legends for Supplementary Figure S1 and Figure S2
Supplementary Figure Legends from C8orf76 Promotes Gastric Tumorigenicity and Metastasis by Directly Inducing Lncrna DUSP5P1 and Associates with Patient Outcomes

Xiaohong Wang,Qiaoyi Liang,Lianhai Zhang,Hongyan Gou,Ziyu Li,Huarong Chen,Dong Yang,Jiafu Ji,Yuanyuan Wang

DOI: https://doi.org/10.1158/1078-0432.22468316.v1

2023-01-01

Abstract:Supplementary Figure legends
Supplementary Figure and Table Legends 1-4 from Combinatorial Pharmacologic Approaches Target EZH2-mediated Gene Repression in Breast Cancer Cells

Shengyu Feng,Eric Chun Yong Chan,Zhenlong Wu,Xiao‐Jun Yang,Víctor E. Márquez,Qiang Yu

DOI: https://doi.org/10.1158/1535-7163.22485608.v1

2023-01-01

Abstract:Supplementary Figure and Table Legends 1-4 from Combinatorial pharmacologic approaches target EZH2-mediated gene repression in breast cancer cells
Supplemental Figure Legends from Expression of GRP78, Master Regulator of the Unfolded Protein Response, Increases Chemoresistance in Pancreatic Ductal Adenocarcinoma

Jenifer B. Gifford,Wei Huang,Ann E. Zeleniak,Antreas Hindoyan,Hong Wu,Timothy R. Donahue,Reginald Hill

DOI: https://doi.org/10.1158/1535-7163.22508517

2023-01-01

Abstract:Figure legends for the supplemental table and each of the supplemental figures.
Supplementary Figure Legends and Table Legends from Targeting LUNX Inhibits Non–Small Cell Lung Cancer Growth and Metastasis

Xiaohu Zheng,Min Cheng,Binqing Fu,Xiaolei Fan,Qing Wang,Xiaoqing Yu,Rui Sun,Zhigang Tian,Haiming Wei

DOI: https://doi.org/10.1158/0008-5472.22407638.v1

2023-01-01

Abstract:Supplementary Figure Legends
Supplementary Figure Legends from PRC2 Epigenetically Silences Th1-Type Chemokines to Suppress Effector T-Cell Trafficking in Colon Cancer

Nisha Nagarsheth,Dongjun Peng,Ilona Kryczek,Ke Wu,Wei Li,Ende Zhao,Lili Zhao,Shuang Wei,Timothy Frankel,Linda Vatan,Wojciech Szeliga,Yali Dou,Scott Owens,Victor Marquez,Kaixiong Tao,Emina Huang,Guobin Wang,Weiping Zou

DOI: https://doi.org/10.1158/0008-5472.22409411.v1

2023-01-01

Abstract:<p>This file contains the legends for the supplementary figures.</p>
Supplementary Figure Legends from Potential Predictive Value of TP53 and KRAS Mutation Status for Response to PD-1 Blockade Immunotherapy in Lung Adenocarcinoma

Zhong-Yi Dong,Wen-Zhao Zhong,Xu-Chao Zhang,Jian Su,Zhi Xie,Si-Yang Liu,Hai-Yan Tu,Hua-Jun Chen,Yue-Li Sun,Qing Zhou,Jin-Ji Yang,Xue-Ning Yang,Jia-Xin Lin,Hong-Hong Yan,Hao-Ran Zhai,Li-Xu Yan,Ri-Qiang Liao,Si-Pei Wu,Yi-Long Wu

DOI: https://doi.org/10.1158/1078-0432.22462077.v1

2023-01-01

Abstract:Supplementary Figure legends

Supplementary Figure Legends from MALAT1 is Associated with Poor Response to Oxaliplatin-Based Chemotherapy in Colorectal Cancer Patients and Promotes Chemoresistance Through EZH2

Supplementary Figure Legends from Intracrine VEGF Signaling Mediates the Activity of Prosurvival Pathways in Human Colorectal Cancer Cells

Supplementary Methods and Supplementary Results from MALAT1 is Associated with Poor Response to Oxaliplatin-Based Chemotherapy in Colorectal Cancer Patients and Promotes Chemoresistance Through EZH2

Supplementary Table 2 from MALAT1 is Associated with Poor Response to Oxaliplatin-Based Chemotherapy in Colorectal Cancer Patients and Promotes Chemoresistance Through EZH2

Supplementary Table 3 from MALAT1 is Associated with Poor Response to Oxaliplatin-Based Chemotherapy in Colorectal Cancer Patients and Promotes Chemoresistance Through EZH2

Supplementary Figure 6 from MALAT1 is Associated with Poor Response to Oxaliplatin-Based Chemotherapy in Colorectal Cancer Patients and Promotes Chemoresistance Through EZH2

Supplementary Figure 4 from MALAT1 Is Associated with Poor Response to Oxaliplatin-Based Chemotherapy in Colorectal Cancer Patients and Promotes Chemoresistance through EZH2

Supplementary Figure Legend from Synergistic Activities of MET/RON Inhibitor BMS-777607 and Mtor Inhibitor AZD8055 to Polyploid Cells Derived from Pancreatic Cancer and Cancer Stem Cells

Supplementary Figure Legends from Retinoic Acid–Related Orphan Receptor C Regulates Proliferation, Glycolysis, and Chemoresistance Via the PD-L1/ITGB6/STAT3 Signaling Axis in Bladder Cancer

Supplementary Figure Legends from EpCAM Inhibition Sensitizes Chemoresistant Leukemia to Immune Surveillance

Supplementary Figure Legends from Nuclear Export of Ubiquitinated Proteins Determines the Sensitivity of Colorectal Cancer to Proteasome Inhibitor

Supplementary Figure Legends from ME1 Regulates NADPH Homeostasis to Promote Gastric Cancer Growth and Metastasis

Supplementary Figure Legends from Combination of TMB and CNA Stratifies Prognostic and Predictive Responses to Immunotherapy Across Metastatic Cancer

Figure Legends for Supplementary Figures from Analysis of Mtor Gene Aberrations in Melanoma Patients and Evaluation of Their Sensitivity to PI3K–AKT–mTOR Pathway Inhibitors

Supplementary Figure Legends from C8orf76 Promotes Gastric Tumorigenicity and Metastasis by Directly Inducing Lncrna DUSP5P1 and Associates with Patient Outcomes

Supplementary Figure and Table Legends 1-4 from Combinatorial Pharmacologic Approaches Target EZH2-mediated Gene Repression in Breast Cancer Cells

Supplemental Figure Legends from Expression of GRP78, Master Regulator of the Unfolded Protein Response, Increases Chemoresistance in Pancreatic Ductal Adenocarcinoma

Supplementary Figure Legends and Table Legends from Targeting LUNX Inhibits Non–Small Cell Lung Cancer Growth and Metastasis

Supplementary Figure Legends from PRC2 Epigenetically Silences Th1-Type Chemokines to Suppress Effector T-Cell Trafficking in Colon Cancer

Supplementary Figure Legends from Potential Predictive Value of TP53 and KRAS Mutation Status for Response to PD-1 Blockade Immunotherapy in Lung Adenocarcinoma